Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Open-Label Intravenous Subanesthetic Ketamine for Adolescents With Treatment-Resistant Depression


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02078817

Organisation Name: University of Minnesota

Overal Status: Completed

Start Date: September 2014

Last Update: January 27, 2020

Lead Sponsor: University of Minnesota

Brief Summary: This study will test the use of ketamine for treatment of depression in adolescents that have not responded to other treatments. We will also examine neurobiological mechanisms of treatment.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.23329901695251